Analyst firms · Robert W. Baird · VIR

Robert W. Baird VIR price target and rating history

Vir Biotechnology Inc. (VIR) · Health Care

Robert W. Baird rates Vir Biotechnology Inc. (VIR) Neutral with a $28 price target, as of its latest action on Mar 3, 2022. It has published 4 rating actions on VIR since December 2021, including 2 upgrades and 2 downgrades.

Current rating
Neutral
Price target
$28
Median target, all firms
Too few
Actions on VIR
4

Robert W. Baird price target on VIR

$36$32$2820222023202420252026
Robert W. Baird price target on VIR, each point a stated target, December 2021 to March 2022.

Every Robert W. Baird rating on VIR

Questions about Robert W. Baird and VIR

What is Robert W. Baird's price target for VIR?
Robert W. Baird's latest stated price target for Vir Biotechnology Inc. (VIR) is $28, from its action on Mar 3, 2022.
What is Robert W. Baird's rating on VIR?
Robert W. Baird rates VIR Neutral, a neutral rating, as of Mar 3, 2022.
When did Robert W. Baird last change its view on VIR?
On Mar 3, 2022, Robert W. Baird upgrades to Neutral from Underperform, price target $36 to $28.

More VIR rating histories

All Robert W. Baird ratingsVIR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.